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Chronic kidney disease (CKD) is characterized by an irreversible decrease in kidney
function and induction of various metabolic dysfunctions. Accumulated findings reveal
that chronic hypoxic stress and endoplasmic reticulum (ER) stress are involved in a
range of pathogenic conditions, including the progression of CKD. Because of the
presence of an arteriovenous oxygen shunt, the kidney is thought to be susceptible
to hypoxia. Chronic kidney hypoxia is induced by a number of pathogenic conditions,
including renal ischemia, reduced peritubular capillary, and tubulointerstitial fibrosis. The
ER is an organelle which helps maintain the quality of proteins through the unfolded
protein response (UPR) pathway, and ER dysfunction associated with maladaptive UPR
activation is named ER stress. ER stress is reported to be related to some of the effects of
pathogenesis in kidney, particularly in the podocyte slit diaphragm and tubulointerstitium.
Furthermore, chronic hypoxia mediates ER stress in blood vessel endothelial cells
and tubulointerstitium via several mechanisms, including oxidative stress, epigenetic
alteration, lipid metabolism, and the AKT pathway. In summary, a growing consensus
considers that these stresses interact via complicated stress signal networks, which
leads to the exacerbation of CKD (Figure 1). This stress signal network might be a target
for interventions aimed at ameliorating CKD.
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INTRODUCTION
CKD is a global public health problem which has substantial impact on morbidity, mortality, and
health resource utilization. The progression of CKD is defined as a decrease in glomerular filtration
rate regardless of primary disease. CKD is related to a variety of metabolic abnormalities including
acidosis, hypertension, anemia, and mineral bone disease (Collister et al., 2016). Chronic hypoxia
of the tubulointerstitium is the common pathway that leads to end stage renal disease (Mimura and
Nangaku, 2010). Hypoxia also triggers ER stress, which further contributes to the progression of
CKD (Inagi et al., 2014). In this review article, we summarize the crosstalk between hypoxia and
ER stress in CKD and explore possible targets for intervention.
PATHOPHYSIOLOGY OF HYPOXIA AND ER STRESS IN KIDNEY
DISEASE
Physiological Hypoxia in Kidney
Hypoxia is a pathologic condition which is characterized by an insufficient supply of oxygen to
meet demand. The blood supply to the kidneys is very large, accounting for roughly 25% of cardiac
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FIGURE 1 | Putative stress signal network between ER stress and hypoxia in CKD. Abbreviations: Epo, erythropoietin; ER, endoplasmic reticulum CKD:
chronic kidney disease; vLDL-R, very low lipoprotein receptor. Hypoxia and ER stress interact through a number of complicated pathways and lead to the
exacerbation of CKD. The progression of CKD is caused via vascular damage, glomerular damage and tubulointerstitial injury. The mechanisms by which ER stress
induces hypoxia include a change of oxygen demand in tissue, dysfunction of iron metabolism and reduction in EPO production. By contrast, chronic hypoxia induces
ER stress through oxidative stress, epigenetic regulation by microRNA, overexpression of vLDL-R and the Akt pathway. These pathogenic factors could be targets for
CKD therapy.
output. However, owing to the presence of an arteriovenous
oxygen shunt in the kidney (Schurek et al., 1990; Welch et al.,
2001), no more than 10% of the oxygen delivered through the
renal artery is utilized (Evans et al., 2008). Oxygen utilization by
the kidney therefore appears to be inefficient, suggesting in turn
that the kidney might be particularly susceptible to hypoxia.
How Kidneys Survive the Hypoxic State
When the kidney is exposed to hypoxia, the expression
of some genes changes. The master regulator of the
adaptation to hypoxia is hypoxia inducible factor (HIF),
a transcription factor. HIF is composed of an α-subunit
(HIF-1α,2α,3α) and β-subunit [HIF-1β/AhR nuclear
translocator (ARNT)]. Although HIF-1β is constitutively
expressed, HIF-α members are degraded in normoxic
conditions. HIF-α is hydroxylated by a prolyl hydroxylase
domain-containing protein (PHD), and the binding of
HIF–α protein to the von Hippel Lindau protein (pVHL)
results in ubiquitination and degradation. Under hypoxia,
HIF-α escapes this degradation and dimerizes with HIF-
1β. The dimer translocates into the nucleus and binds
to the hypoxia-response element (HRE) of HIF-target
genes. This results in the activation of target genes
involved in angiogenesis, erythropoiesis, and glycolysis
(Mimura and Nangaku, 2010; Shoji et al., 2014).
Pathogenic Hypoxia in the Kidney
Various pathogenic conditions induce chronic kidney hypoxia,
including hypertension and diabetes. Some studies have shown
that following renal ischemia, density of the peritubular
capillaries decreases, as does oxygen tension in the kidney (Basile
et al., 2001, 2003). Furthermore, the systemic hemodynamic
changes and vasoconstriction associated with the renin-
angiotensin system result in a decrease in peritubular capillary
flow (Korner et al., 1994). Hypoxia might also be induced
via tubulointerstitium fibrosis, in which the distance between
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the capillary and tubular cells is extended, leading to further
impairment of oxygen delivery (Norman and Fine, 2006). In
addition, some conditions increase oxygen demand, including
glomerular hyperfiltration induced by hyperglycemia, (Korner
et al., 1994), and anemia decreases oxygen delivery to the kidney
(Johannes et al., 2007).
ER Stress and Its Stress Signal UPR
Pathway
The ER is the main organelle involved in the quality control
of proteins. This process, termed proteostasis, involves protein
synthesis, protein folding, and the degradation of malfolded
proteins. The quality of proteins is maintained through the UPR
pathway, an integrated pathway which transduces information
about protein folding conditions from the ER to the nucleus
by controlling the activity of specific downstream transcription
factors (Inagi et al., 2014; Rivas et al., 2015). The adaptive UPR
pathway is regulated by the three major pathway transducers
present in the ER lumen, named inositol-requiring protein 1
(IRE1), pancreatic eukaryotic translation initiation factor 2α
(eIF2α) kinase (PERK) and activating transcription factor 6
(ATF6). These transducers are kept in an inactive state in normal
conditions via binding to the ER chaperon GRP78 (78 kD
glucose-regulated protein). However, the maintenance of protein
metabolism is disturbed under various pathogenic stresses,
including hypoxia. This disturbance results in the accumulation
of unfolded proteins through ER dysfunction, which in turn
causes cell damage. This series of events is termed ER stress.
Under ER stress, GRP78 is dissociated from transducers and
binds to unfolded proteins. The free transducers are thus
activated, causing the UPR transcription factors, including X-
box-binding protein 1 (XBP1) and ATF4, to translocate into
the nucleus. This translation leads to up-regulation of the
expression of UPR-target genes involved in protein folding
and ER-associated protein degradation (ERAD). Activated ATF6
translocates into the Golgi apparatus and is cleaved to form
ATFp50, a transcription factor which activates the expression of
the UPR-target gene related to ERAD. However, if the adaptive
UPR pathway is overcome by chronic or severe ER stress and
proteostasis cannot be maintained, the predominant outcome is
the induction of ER stress-related apoptosis, which occurs via
the activation of C/EBP homologous protein (CHOP) (Kimata
et al., 2004; Inagi, 2010; Pincus et al., 2010). ER stress is
associated with many diseases, including diabetes (Rivas et al.,
2015), chronic heart failure (Cominacini et al., 2015) and some
neurodegenerative diseases (Soto, 2003). Moreover, many recent
studies have reported a relationship between the UPR pathway
and glomerular and tubular cell damage in various kidney
diseases (Inagi et al., 2014).
Pathophysiology of ER Stress in Kidney Disease
Many studies have revealed the effects of the pathogenesis of
the UPR pathway in the kidney. The podocyte slit diaphragm
is important as a glomerular filtration barrier. The structural
components of the slit diaphragm [nephrin, alpha-actinin-4, and
CD2-associated protein (CD2AP)] are subject to a mutation
which causes defective protein folding in the ER of podocytes.
The accumulation of malfolded proteins of the slit diaphragm
induces structural and functional damage associated with ER
stress and subsequent proteinuria (Cybulsky et al., 2009; Chiang
and Inagi, 2010; He et al., 2011). Various pathogenic factors
also trigger ER stress in podocytes, including complement
complex (Cybulsky, 2013) and calcium entry via transient
receptor protein 6 (TRPC6) (Chen et al., 2011). ER stress
also injures podocytes via increased expression of monocyte
chemoattractant protein 1 (MCP-1), which plays a central role
in the inflammation associated with diabetic nephropathy. The
structural and functional properties of tubular epithelial cells are
closely dependent on ER proteostasis. Exposure of tubular cells
to severe or long-term stress induces UPR pathway-mediated
apoptosis and leads to the progression of CKD. Well-known
examples of adverse factors that induce UPR pathway-related
cell apoptosis, reduce the repair capacity of tubular cells and
accelerate the progression of kidney disease include proteinuria
(Ohse et al., 2006), hyperglycemia (Lindenmeyer et al., 2008),
uremic toxins (Kawakami et al., 2010), and nephrotoxins,
including cisplatin (Ozkok and Edelstein, 2014). Furthermore,
ER stress has also been demonstrated in a unilateral ureteral
obstruction tubulointerstitial fibrosis rat model (Chiang et al.,
2011), in which excessive UPR activation over the adaptive UPR
pathway contributed to tubular cell apoptosis and the resulting
fibrosis.
INTERACTION OF HYPOXIA AND ER
STRESS
Hypoxia to ER Stress
Chronic hypoxia triggers ER stress. Hypoxia induces cell stress,
which leads the production of reactive oxygen species (ROS), a
situation termed oxidative stress. ROS are produced in several
organelles, including the ER. Altered redox homeostasis in the
ER cause ER stress. These findings indicate a close link between
hypoxia, oxidative stress, and ER stress (Sena and Chandel, 2012;
Cao and Kaufman, 2014; Inagi et al., 2014). For example, we
previously reported the epigenetic regulation of the cross-talk
of hypoxia-oxidative stress-ER stress by microRNA. We found
that miR-205, a microRNA which is predominantly expressed in
kidney tubular cells, maintains tubular homeostasis by regulating
the expression of PHD1, which negatively controls HIF1α and
ATF4. HIF1α is a transcription factor of the HIF pathway
and ATF4 is a transcription factor of the URP pathway, and
the two act together to regulate antioxidant enzyme expression
(Muratsu-Ikeda et al., 2012). Furthermore, hypoxia results in
activation of the PERK/eIF2α axis of the UPR pathway by Akt
(also known as protein kinase B or PKB), a serine/threonine
kinase member of the AGC family of protein kinases which is
involved in cell growth, proliferation, protein translation, and cell
survival. Cells without Akt isoform 1 and 2 do not induce either
PERK or eIF2α phosphorylation, even in hypoxic conditions,
demonstrating that Akt mediates PERK/eIF2α activation during
hypoxia (Blaustein et al., 2013). In addition, hypoxia triggers ER
stress and induces very low density lipoprotein receptors (vLDL-
R) in vessel endothelial cells. Knockdown or overexpression of
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vLDL-R improves or exacerbates hypoxia-induced ER stress,
demonstrating that vLDL-R induces endothelial cell apoptosis
via ER stress (Yang et al., 2014). Thus, these mechanisms
might be targets for interventions aimed at preventing the
CKD progression associated with vessel and tubulointerstitial
damage.
ER Stress to Hypoxia
ER stress is reported to suppress the production of erythropoietin
(EPO), a hematopoietic hormone regulated by the HIF pathway.
This suppression of EPO by ER stress is inversely correlated with
ATF4 expression, and the binding of ATF4 to the 3′ enhancer
region of EPO gene abolished the enhancer activity (Chiang et al.,
2013). ER stress also changes ferrokinetics. Hepcidin is a peptide
hormone secreted by the liver which controls iron homeostasis.
The production of Hepcidin is mediated by inflammation
and iron. The overproduction of hepcidin causes anemia, but
its deficiency leads to hemochromatosis. One report revealed
that ER stress also induces hepcidin expression and causes
hypoferremia in mice. CREBH (cyclic AMP response element–
binding protein H), an ER stress–activated transcription factor,
binds to and trans-activates the hepcidin promoter. Hepcidin
induction in response to exogenously administered toxins or
the accumulation of unfolded proteins in the ER is defective
in CREBH knockout mice, indicating a role for CREBH in ER
stress–regulated hepcidin expression (Vecchi et al., 2009). These
reports indicate that ER stress is related to hematopoiesis and
iron metabolism, and that ER stress might therefore be related
to hypoxia via the mediation of anemic conditions.
The mechanisms described above could lead to a decrease
in kidney function via deteriorating hypoxia by induction of
anemia. In turn, a decrease in kidney function results in
the accumulation of uremic toxins. Indoxyl sulfate (IS), a
representative uremic toxin, induces ER stress in cultured human
proximal tubular cells, as demonstrated by an increase in CHOP,
and inhibits the proliferation/repair of tubular cells (Kawakami
et al., 2010). Moreover, IS also increases oxygen consumption in
kidney proximal tubular cells and decreases renal oxygenation.
On the other hand, IS suppresses mRNA expression of EPO,
demonstrating a link between IS and hypoxia as well as ER
stress (Chiang et al., 2011). In fact, IS suppresses the induction
of HIF-1 target gene expression in hypoxic conditions through
dysfunction of the HIF-1α C-terminal transactivation domain
(CTAD). The suppression of HIF-1 activity by IS is correlated
with up-regulation of CBP/p300-interacting transactivator with
the Glu/Asp-rich carboxy-terminal domain 2 (CITED2), which
is a negative regulator of HIF-1 activity. Namely, IS increases
CITED2 expression via post-transcriptional mRNA stabilization
(Tanaka et al., 2013). Asai et al have shown that IS suppresses HIF
activation, and subsequent EPO production via AhR activation,
and that AhR blockade improves IS-induced suppression of HIF
activation (Asai et al., 2016). These findings suggest that IS
may be a pathogen that perturbs cross-talk between the UPR
pathway of ER stress and the HIF pathway of hypoxia. Taken
together, these findings indicate that the removal of IS, blockage
of AhR, inhibition of hepcidin production and mediation of the
UPR pathway, including ATF4, might be therapeutic targets in
ameliorating hypoxia and subsequent CKD progression.
CONCLUSION
Hypoxia and ER stress act together to induce a deterioration
in kidney function. This adverse effect is mediated by the
formation of a complicated signal network between them.
Furthermore, uremic toxins such as IS also induce ER stress and
subsequent hypoxia through suppression of erythropoiesis and
the exacerbation of tubular fibrosis. These pathogenic factors
could be targets for CKD therapy.
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